Jove
Visualize
Contact Us

Related Experiment Videos

Age-related osteoporosis.

C D Rubin1

  • 1Dept. of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8889.

The American Journal of the Medical Sciences
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Osteoporosis affects millions, causing fractures and significant costs. This review examines age-related bone changes and treatment options like calcium and estrogen for elderly patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential activation on fMRI of monozygotic twins discordant for AD.

Neurology·2003
Same author

Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.

Archives of internal medicine·2001
Same author

Evaluation and treatment of postmenopausal osteoporosis.

The American journal of managed care·2001
Same author

Treatment considerations in the management of age-related osteoporosis.

The American journal of the medical sciences·1999
Same author

Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis.

The American journal of the medical sciences·1997
Same author

Twenty-four hour growth hormone secretion in a patient with Werner's syndrome.

Experimental gerontology·1996
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Gerontology
  • Bone Physiology
  • Pharmacology

Background:

  • Osteoporosis is a prevalent condition leading to substantial morbidity, mortality, and financial burden, with 1.2 million fractures annually in the U.S.
  • Current research often overlooks age-related differences, focusing primarily on early postmenopausal individuals.
  • Significant epidemiologic, physiologic, and clinical distinctions exist between early postmenopausal women and older individuals.

Purpose of the Study:

  • To review age-related changes in bone physiology pertinent to osteoporosis.
  • To evaluate the evidence for commonly used and approved osteoporosis treatments in the elderly population.

Main Methods:

  • Literature review focusing on age-related bone physiology.
  • Analysis of studies evaluating calcium, estrogen, and calcitonin in older adults.

Related Experiment Videos

Main Results:

  • Age-related bone physiology differs significantly from that in younger individuals.
  • Evidence for the efficacy and safety of certain osteoporosis treatments in the elderly requires careful consideration.

Conclusions:

  • Generalizing treatment recommendations from younger to older patients with osteoporosis may not be appropriate.
  • Further research is needed to optimize osteoporosis management in the elderly, considering specific age-related factors.